Patient Conversations: Managing Patient Expectations Regarding Biosimilars
Key topics for patient-provider conversations within the biosimilar landscape are highlighted by expert panelists.
Source: ajmc.com
📰 Bincy Abraham News
Bincy Abraham News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bincy Abraham. Real-time updates on events, politics, business and more.
Key Points of Emphasis Regarding Biosimilar Integration
Panelists provide final considerations surrounding biosimilar usage and considerations for optimal patient care.
Source: ajmc.com
Vitamin D Linked to Clinical, Endoscopic Outcomes of Vedolizumab Treatment for IBD
Pretreatment vitamin D levels were associated with endoscopic improvement in patients with UC and decreased C-reactive protein levels in patients with CD.
Bincy Abraham Fondren Inflammatory Bowel Disease Program Underwood Center Houston Methodist Digestive Disorders Houston Methodist Hospital
Source: hcplive.com
An Overview of Biosimilar Extrapolation During FDA Approval
Specialists define and discuss extrapolation, along with the importance of strong data in specific disease states.
Source: ajmc.com
Harnessing Indication-Specific Data on Biosimilars
Professionals explore the importance of indication-specific data in gastroenterology.
Source: ajmc.com
Evolution of Auto-Substitution in Biosimilar Landscape
Professionals speak to auto-substitution and its Impact on the shared decision-making process associated with biosimilars.
Source: ajmc.com
Defining Interchangeability and Switching in Biologics
Medical experts discuss interchangeability designation requirements for biosimilars.
Source: ajmc.com
Initiating Biosimilar Treatment in Patients Without Previous Reference Biologic Experience
Vibeke Strand, MD, evaluates implementation of biosimilars in patients with no history of reference biologic use.
Source: ajmc.com
Switching Patients from Reference Product to Biosimilar
Insight surrounding the switch from reference drugs to biosimilars is provided by Bincy Abraham, MD, MS.
Source: ajmc.com
Biosimilar Administration Considerations Impacting Patient Experience
Panelists discuss reference biologic and biosimilar concentrations as well as the importance of citrate-free, less frequent injectable medications.
Source: ajmc.com